Press Releases

Date	Title	Company
27-Sep-2023	Aquaculture Vaccine Market Poised to reach US$ 913.6 Million by 2033, Fuelled by Rising Global Aquaculture Production: FMI Study	MARKITWIRED
27-Sep-2023	Encephalitis Management Market Envisioned to Exceed US$ 34.08 Billion by 2033, Driven by Advances in Encephalitis Recovery \| FMI	MARKITWIRED
27-Sep-2023	Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy	Evotec SE
27-Sep-2023	Synergistic Approaches and Innovative Assays Are Poised To Drive the Complicated Urinary Tract Infection Treatment Market at a CAGR Of 5.76%, As Per FMI	MARKITWIRED
27-Sep-2023	Generalized Myasthenia Gravis (GMG) Managements Market to Reach a Valuation of US$ 2.96 Billion by 2033 Due to Growing Geriatric Population Globally	MARKITWIRED
27-Sep-2023	Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa	Cosmo Pharmaceuticals N.V.
27-Sep-2023	Increasing Demand for Frontotemporal Dementia Management to Propel the Growth at 6% CAGR through 2033: FMI Study	MARKITWIRED
27-Sep-2023	Global Market for Tuberculous Meningitis Treatment to expand at a 7.2% CAGR from 2023 to 2033, reaching US$ 300 Billion: FMI Report	MARKITWIRED
27-Sep-2023	Idiopathic Pulmonary Fibrosis Management Market to Reach US$ 3649.90 Million by 2033: Focus on Developing New Drugs and Therapies \| FMI	MARKITWIRED
26-Sep-2023	Alpha-1 Antitrypsin Deficiency Market Booms to US$10 Billion by 2033, Propelled by a Noteworthy 12.8% CAGR \| FMI Report	MARKITWIRED
26-Sep-2023	FMI Reveals Remarkable Forecast for the Chronic Obstructive Pulmonary Disease (COPD): Expected to Reach US$33.19 Billion with a 4.4% CAGR by 2033	MARKITWIRED
26-Sep-2023	AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conference	AlzeCure
26-Sep-2023	Oncopeptides announces successful price negotiations for Pepaxti in Germany	Oncopeptides AB
26-Sep-2023	UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in Japan	UCB
26-Sep-2023	XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke	XBiotech Inc.
26-Sep-2023	Northern Gritstone and Argobio Studio back Sheffield University spin-out Crucible Therapeutics	Crucible Therapeutics
26-Sep-2023	FMI Report Predicts Remarkable 7.9% CAGR, Forecasting US$5.91 Billion Valuation for Dental Imaging Equipment Market by 2030	MARKITWIRED
26-Sep-2023	Breast Imaging Market’s Exceptional 7.1% CAGR Transformation, Predicting US$8.5 Billion by 2032 \| FMI Analysis Revealed	MARKITWIRED
26-Sep-2023	Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review	Regeneron Pharmaceuticals
26-Sep-2023	In vitro lung cell exposure systems by VITROCELL at EUROTOX 2023	VITROCELL